Cibus (NASDAQ:CBUS) Earns Buy Rating from HC Wainwright

Cibus (NASDAQ:CBUS)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Friday,Benzinga reports. They currently have a $25.00 price target on the stock. HC Wainwright also issued estimates for Cibus’ Q1 2025 earnings at ($0.66) EPS, Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.

Separately, Canaccord Genuity Group reduced their price target on Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Wednesday, January 22nd.

Cibus Stock Performance

Shares of NASDAQ:CBUS opened at $2.05 on Friday. Cibus has a 1 year low of $1.80 and a 1 year high of $23.18. The stock has a market capitalization of $54.23 million, a P/E ratio of -0.09 and a beta of 2.04. The stock has a 50-day simple moving average of $2.33 and a 200-day simple moving average of $3.33.

Cibus (NASDAQ:CBUS) last released its quarterly earnings results on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.19). The company had revenue of $1.21 million for the quarter, compared to analyst estimates of $1.13 million. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. Analysts predict that Cibus will post -2.96 earnings per share for the current year.

Hedge Funds Weigh In On Cibus

Institutional investors have recently made changes to their positions in the business. IFP Advisors Inc acquired a new position in shares of Cibus in the 4th quarter valued at approximately $36,000. B. Riley Wealth Advisors Inc. acquired a new position in shares of Cibus in the 3rd quarter valued at approximately $44,000. Virtu Financial LLC acquired a new position in shares of Cibus in the 3rd quarter valued at approximately $48,000. HighTower Advisors LLC raised its position in shares of Cibus by 20.6% in the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after purchasing an additional 2,750 shares in the last quarter. Finally, Sei Investments Co. acquired a new position in shares of Cibus in the 4th quarter valued at approximately $49,000. 33.81% of the stock is owned by institutional investors and hedge funds.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.